Hebang Biotechnology expects 2024 H1 performance reduction

Summary: On 10 July, Hebang Biotechnology issued a 2024 half-yearly performance reduction announcement, stating that the Q2 operating results were better than Q1. Moving forward, the company is set to further develop its market presence in the glypho...

Herbicides China Monthly Report 202407

www.cnchemicals.com